Literature DB >> 3028378

Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.

U H Lerner, B B Fredholm, M Ransjö.   

Abstract

The effect of the adenylate cyclase activator forskolin on bone resorption and cyclic AMP accumulation was studied in an organ-culture system by using calvarial bones from 6-7-day-old mice. Forskolin caused a rapid and fully reversible increase of cyclic AMP, which was maximal after 20-30 min. The phosphodiesterase inhibitor rolipram (30 mumol/l), enhanced the cyclic AMP response to forskolin (50 mumol/l) from a net cyclic AMP response of 1234 +/- 154 pmol/bone to 2854 +/- 193 pmol/bone (mean +/- S.E.M., n = 4). The cyclic AMP level in bones treated with forskolin (30 mumol/l) was significantly increased after 24 h of culture. Forskolin, at and above 0.3 mumol/l, in the absence and the presence of rolipram (30 mumol/l), caused a dose-dependent cyclic AMP accumulation with an calculated EC50 (concentration producing half-maximal stimulation) value at 8.3 mumol/l. In 24 h cultures forskolin inhibited spontaneous and PTH (parathyroid hormone)-stimulated 45Ca release with calculated IC50 (concentration producing half-maximal inhibition) values at 1.6 and 0.6 mumol/l respectively. Forskolin significantly inhibited the release of 3H from [3H]proline-labelled bones stimulated by PTH (10 nmol/l). The inhibitory effect by forskolin on PTH-stimulated 45Ca release was significant already after 3 h of culture. In 24 h cultures forskolin (3 mumol/l) significantly inhibited 45Ca release also from bones stimulated by prostaglandin E2 (1 mumol/l) and 1 alpha-hydroxycholecalciferol (0.1 mumol/l). The inhibitory effect of forskolin on spontaneous and PTH-stimulated 45Ca release was transient. A dose-dependent stimulation of basal 45Ca release was seen in 120 h cultures, at and above 3 nmol of forskolin/l, with a calculated EC50 value at 16 nmol/l. The stimulatory effect of forskolin (1 mumol/l) could be inhibited by calcitonin (0.1 unit/ml), but was insensitive to indomethacin (1 mumol/l). Forskolin increased the release of 3H from [3H]proline-labelled bones cultured for 120 h and decreased the amount of hydroxyproline in bones after culture. Forskolin inhibited PTH-stimulated release of Ca2+, Pi, beta-glucuronidase and beta-N-acetylglucosaminidase in 24 h cultures. In 120 h cultures forskolin stimulated the basal release of minerals and lysosomal enzymes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028378      PMCID: PMC1147447          DOI: 10.1042/bj2400529

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Studies on bone enzymes. The assay of acid hydrolases and other enzymes in bone tissue.

Authors:  G Vaes; P Jacques
Journal:  Biochem J       Date:  1965-11       Impact factor: 3.857

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

3.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Inhibition of bone resorption and lysosomal enzyme release from calvarial bones cultured for 24 hours: synergism between cyclic AMP analogues and phosphodiesterase inhibitors.

Authors:  U Lerner
Journal:  Acta Endocrinol (Copenh)       Date:  1980-05

5.  Physical and functional properties of adenylate cyclase from mature rat testis.

Authors:  E J Neer
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

6.  Inhibitory effect of dibutyryl cyclic AMP on the release of calcium, inorganic phosphate and lysosomal enzymes from calvarial bones cultured for 24 hours.

Authors:  U Lerner; G T Gustafson
Journal:  Acta Endocrinol (Copenh)       Date:  1979-08

Review 7.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

8.  A two-receptor model for the action of parathyroid hormone on osteoblasts: a role for intracellular free calcium and cAMP.

Authors:  C W Löwik; J P van Leeuwen; J M van der Meer; J K van Zeeland; B A Scheven; M P Herrmann-Erlee
Journal:  Cell Calcium       Date:  1985-08       Impact factor: 6.817

9.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

10.  Comparison of inhibition of bone resorption and escape with calcitonin and dibutyryl 3',5' cyclic adenosine monophosphate.

Authors:  J F McLeod; L G Raisz
Journal:  Endocr Res Commun       Date:  1981
View more
  6 in total

1.  Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel.

Authors:  S E Guggino; D Lajeunesse; J A Wagner; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Interleukin 1 interacts synergistically with forskolin and isobutylmethylxanthine in stimulating bone resorption in organ culture.

Authors:  F E Dewhirst; J M Ago; P Stashenko
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

3.  Parathyroid hormone and prostaglandin E2 stimulate both inositol phosphates and cyclic AMP accumulation in mouse osteoblast cultures.

Authors:  R W Farndale; J R Sandy; S J Atkinson; S R Pennington; S Meghji; M C Meikle
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Caffeine has the capacity to stimulate calcium release in organ culture of neonatal mouse calvaria.

Authors:  U H Lerner; D Mellström
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

5.  Study on site-specific expression of bone formation and resorption factors in human dental follicles.

Authors:  Pamela Uribe; Pawel Plakwicz; Lena Larsson; Ewa Czochrowska; Anna Westerlund; Maria Ransjö
Journal:  Eur J Oral Sci       Date:  2018-09-14       Impact factor: 2.612

6.  Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Authors:  Jialing Wu; Xinyu Wu; Zena Chen; Qing Lv; Mingcan Yang; Xuqi Zheng; Qiuxia Li; Yanli Zhang; Qiujing Wei; Shuangyan Cao; Xiaomin Li; Jun Qi; Minjing Zhao; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.